[Relation between corpus luteum function and serum prolactin concentration early in pregnancy]

Area of Science:

• Reproductive Endocrinology
• Pharmacology

Context:

• Early pregnancy (6-8 weeks gestation) involves dynamic hormonal changes.
• Metoclopramide is a dopamine antagonist with known effects on prolactin secretion.
• Corpus luteum function is critical for maintaining early pregnancy through steroid hormone production.

Purpose:

• To investigate the impact of metoclopramide-induced hyperprolactinemia on corpus luteum function during early pregnancy.
• To assess changes in progesterone and estradiol levels following metoclopramide administration.

Summary:

• In 23 pregnant patients (6-8 weeks), a 10 mg metoclopramide bolus injection caused a significant increase in serum prolactin concentration.
• Serum levels of progesterone and estradiol were monitored to assess corpus luteum steroid secretion.
• No alterations in corpus luteum function were observed despite the induced hyperprolactinemia.

Impact:

• This study suggests that transient hyperprolactinemia induced by metoclopramide does not compromise corpus luteum function in early pregnancy.
• Findings are relevant for understanding the safety of metoclopramide use during early gestation.
• Provides evidence that the corpus luteum may be resilient to acute prolactin level fluctuations in this period.